本页面由Tiger Trade Technology Pte. Ltd.提供服务

BioLine Rx

2.26
+0.05002.26%
成交量:2,132.00
成交额:4,822.16
市值:983.41万
市盈率:-7.90
高:2.28
开:2.21
低:2.21
收:2.21
52周最高:7.77
52周最低:2.15
股本:435.14万
流通股本:417.35万
量比:3.94
换手率:0.05%
股息:- -
股息率:- -
每股收益(TTM):-0.2860
每股收益(LYR):-0.2856
净资产收益率:-11.01%
总资产收益率:-16.11%
市净率:0.54
市盈率(LYR):-7.91

数据加载中...

2021/01/29

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/20

[补充]招股说明书

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2021/01/19

[补充]招股说明书

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2021/01/11

SEC问询函

CORRESP [Cover] - Correspondence
2021/01/06

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/11/23

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/11/03

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/07/01

SEC问询函

CORRESP [Cover] - Correspondence
2020/06/26

招股说明书

F-1 - Registration statement for certain foreign private issuers
2020/06/05

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/06/05

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/06/05

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/06/02

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/05/26

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/05/20

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/12

年度报告

Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/03/12

财报披露

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/05

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/27

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/14

超过5%披露

Statement of acquisition of beneficial ownership by individuals